Egg Medical Unveils Trial Showing Apron-Free Protection For Interventional Teams

KUALA LUMPUR, March 11 (Bernama) -- Egg Medical, a leader in enhanced radiation protection devices (ERPD), has unveiled the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference.

“Our goal is to give clinicians a choice, but one backed by rigorous, published data. By providing personalised data through live dosimetry, the EggNest supports apron-free or ultralight apron workflows where approved, rather than forcing a specific behaviour,” said Egg Medical Chief Commercial Officer, Gavin Philipps in a statement.

Presented by Santiago Garcia of The Christ Hospital, the study confirms that the EggNest system significantly reduces levels of scatter radiation for all members of the interventional team, whereby users could perform procedures safely without lead aprons or while wearing ultralight aprons.